219 related articles for article (PubMed ID: 33086994)
1. Successful use of short-term add-on tocilizumab for refractory adult-onset still's disease with macrophage activation syndrome despite treatment with high-dose glucocorticoids, cyclosporine, and etoposide.
Ohmura SI; Uehara K; Yamabe T; Tamechika S; Maeda S; Naniwa T
Mod Rheumatol Case Rep; 2020 Jul; 4(2):202-207. PubMed ID: 33086994
[TBL] [Abstract][Full Text] [Related]
2. Benefit and a possible risk of tocilizumab therapy for adult-onset Still's disease accompanied by macrophage-activation syndrome.
Kobayashi M; Takahashi Y; Yamashita H; Kaneko H; Mimori A
Mod Rheumatol; 2011 Feb; 21(1):92-6. PubMed ID: 20737186
[TBL] [Abstract][Full Text] [Related]
3. A Recurrent Case of Adult-onset Still's Disease with Concurrent Acalculous Cholecystitis and Macrophage Activation Syndrome/Hemophagocytic Lymphohistiocytosis Successfully Treated with Combination Immunosuppressive Therapy.
Arai Y; Ishikawa Y; Abe K; Kato Y; Abe D; Fujiwara M; Kita Y
Intern Med; 2021 Jun; 60(12):1955-1961. PubMed ID: 33518559
[TBL] [Abstract][Full Text] [Related]
4. Rescued from desperation: adult-onset Still's disease with life-threatening interstitial lung disease and macrophage activation : Successful treatment by Tocilizumab.
Zhang G; Liu W; Zhang X; Liu L
Z Rheumatol; 2022 May; 81(4):335-338. PubMed ID: 34378080
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of glucocorticoid and cyclosporine refractory adult-onset Still's disease complicated with hemophagocytic syndrome with plasma exchange therapy and tocilizumab : a case report.
Komiya Y; Takenaka K; Nagasaka K
Nihon Rinsho Meneki Gakkai Kaishi; 2013; 36(6):478-83. PubMed ID: 24390109
[TBL] [Abstract][Full Text] [Related]
6. Short-term, low-dose etoposide in refractory adult-onset Still's disease-associated macrophage activation syndrome.
Wang R; Li T; Ye S; Lv L; Chen S; Wang X; Bao CD; Fu Q
Clin Rheumatol; 2022 Sep; 41(9):2817-2823. PubMed ID: 35590113
[TBL] [Abstract][Full Text] [Related]
7. Macrophage activation syndrome complicating adult onset Still's disease: A single center case series and comparison with literature.
Lenert A; Yao Q
Semin Arthritis Rheum; 2016 Jun; 45(6):711-6. PubMed ID: 26672682
[TBL] [Abstract][Full Text] [Related]
8. Baseline clinical features predicting macrophage activation syndrome in patients with systemic adult-onset Still's disease receiving interleukin-6 inhibitor treatment.
Naniwa T; Yamabe T; Ohmura SI; Uehara K; Tamechika SY; Maeda S; Isogai S; Wada J
Int J Rheum Dis; 2022 Sep; 25(9):1003-1012. PubMed ID: 35719030
[TBL] [Abstract][Full Text] [Related]
9. Adult macrophage activation syndrome-haemophagocytic lymphohistiocytosis: 'of plasma exchange and immunosuppressive escalation strategies' - a single centre reflection.
Lorenz G; Schul L; Schraml F; Riedhammer KM; Einwächter H; Verbeek M; Slotta-Huspenina J; Schmaderer C; Küchle C; Heemann U; Moog P
Lupus; 2020 Mar; 29(3):324-333. PubMed ID: 32013725
[TBL] [Abstract][Full Text] [Related]
10. Reintroduction of tocilizumab elicited macrophage activation syndrome in a patient with adult-onset Still's disease with a previous successful tocilizumab treatment.
Naniwa T; Uehara K; Yamabe T; Ohmura SI
Mod Rheumatol Case Rep; 2021 Jul; 5(2):360-364. PubMed ID: 32883165
[TBL] [Abstract][Full Text] [Related]
11. [Adult onset Still's disease with small vessel vasculitis].
Hoff P; Hoyer BF; Schneider U; Kneitz C; Burmester GR; Buttgereit F
Z Rheumatol; 2015 Aug; 74(6):540-2. PubMed ID: 26231832
[TBL] [Abstract][Full Text] [Related]
12. [Not Available].
Plate A; Vallelian F; Herfs G
Praxis (Bern 1994); 2016; 105(25):1503-1506. PubMed ID: 27976958
[No Abstract] [Full Text] [Related]
13. Acquired Amegakaryocytic Thrombocytopenia in Adult-onset Still's Disease: Successful Combination Therapy with Tocilizumab and Cyclosporine.
Ichikawa T; Shimojima Y; Otuki T; Ueno KI; Kishida D; Sekijima Y
Intern Med; 2019 Dec; 58(23):3473-3478. PubMed ID: 31391399
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoid and cyclosporine refractory adult onset Still's disease successfully treated with tocilizumab.
Matsumoto K; Nagashima T; Takatori S; Kawahara Y; Yagi M; Iwamoto M; Okazaki H; Minota S
Clin Rheumatol; 2009 Apr; 28(4):485-7. PubMed ID: 19184270
[TBL] [Abstract][Full Text] [Related]
15. Reactive macrophage activation syndrome possibly triggered by canakinumab in a patient with adult-onset Still's disease.
Banse C; Vittecoq O; Benhamou Y; Gauthier-Prieur M; Lequerré T; Lévesque H
Joint Bone Spine; 2013 Dec; 80(6):653-5. PubMed ID: 23751410
[TBL] [Abstract][Full Text] [Related]
16. Macrophage activation syndrome in patients with adult-onset Still's disease under tocilizumab treatment: A single-center observational study.
Yamabe T; Ohmura SI; Uehara K; Naniwa T
Mod Rheumatol; 2022 Jan; 32(1):169-176. PubMed ID: 33719871
[TBL] [Abstract][Full Text] [Related]
17. A continuous infusion of etoposide and doxorubicin for refractory MAS management.
Jin J
Neth J Med; 2016 Aug; 74(7):324-5. PubMed ID: 27571955
[No Abstract] [Full Text] [Related]
18. An unusual case of adult-onset still's disease complicated with anti-complement factor H antibodies associated atypical haemolytic uraemic syndrome.
Fung WW; Chao AC; Pang WF; Wong RS; Chow KM; Szeto CC
BMC Nephrol; 2024 May; 25(1):164. PubMed ID: 38745129
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of macrophage activation syndrome complicating adult Still disease with anakinra.
Loh NK; Lucas M; Fernandez S; Prentice D
Intern Med J; 2012 Dec; 42(12):1358-62. PubMed ID: 23253002
[TBL] [Abstract][Full Text] [Related]
20. [CME: Adult Still disease].
Etter M; Vallelian F; Herfs G
Praxis (Bern 1994); 2015 Oct; 104(21):1117-25. PubMed ID: 26463902
[No Abstract] [Full Text] [Related]
[Next] [New Search]
